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Ubiquitin is a common demoninator in the targeting of substrates to all three major protein degra-
dation pathways in mammalian cells: the proteasome, the lysosome, and the autophagosome. The
factors that direct a substrate toward a particular route of degradation likely include ubiquitin chain
length and linkage type, which may favor interaction with particular receptors or confer differential
susceptibility to deubiquitinase activities associated with each pathway.The dynamic state of bodily proteins was established by
analyzing the fate of stable isotope-labeled amino acids that
had been fed to mice. These classic experiments, conducted
by Rudolf Schoenheimer in the late 1930s, presage modern
stable isotope labeling techniques (such as SILAC), which allow
determination of the turnover rate of hundreds to thousands of
individual proteins in a single mass spectrometry experiment
(Kristensen et al., 2008). After its discovery, the lysosomal
compartment was considered the principal site of degradation
of cellular proteins, through the action of resident acid-depen-
dent proteases. However, this view perished with the demon-
stration that the half-lives of most cellular proteins are insensitive
to alkalinization of the lysosomes. The subsequent discovery of
the ubiquitin-proteasome degradation system as themajor route
to protein degradation generated a new orthodoxy. Central to
this model is the idea that covalent modification of substrate
proteins with a polypeptide ubiquitin tag targets them to the large
(26S) proteolytic complex known as the proteasome.
It came thenasasurprise todiscover that ubiquitin taggingalso
provides a signal to route endocytosed receptors to the lyso-
somal degradation pathway and more recently to mark organ-
elles for disposal by the third major cellular degradative pathway
of autophagocytosis. The role of ubiquitin in protein degradation
is more ubiquitous than once thought (Figure 1). In this Minire-
view, we consider how a ubiquitin tag selects for specific degra-
dation pathways and also highlight the interplay between these
pathways that a shared dependence on ubiquitin engenders.General Considerations
Substrate proteins are selected for modification of lysine resi-
dues by ubiquitin through interaction with an E3 ligase protein
that recruits an E2-enzyme charged with ubiquitin. This can
result in transfer of a single ubiquitin molecule (monoubiquitina-
tion) or coupling of further ubiquitin molecules, through integral
lysine residues, to form a chain. The seven lysines of ubiquitin
provide for the formation of different isopeptide chain linkages,
which adopt different three-dimensional structures, and all of
which are represented in eukaryotic cells (Xu et al., 2009). The
specific combination of E2 and E3 enzymes recruited to682 Cell 143, November 24, 2010 ª2010 Elsevier Inc.a substrate dictates the chain linkage type. The human genome
encodes more than 20 different types of ubiquitin-binding
domains, and proof of principle for linkage specificity of binding
has been established (see Essay by F. Ikeda, N. Crosetto, and
I. Dikic on page 677 of this issue). One means to achieve this is
through the spatial arrangement of tandem ubiquitin-binding
domains (UBDs) either encoded in a single protein or by
combining domains within a multimolecular complex, such that
simultaneous occupancy of two binding sites is restricted to
particular chain configurations.Proteasomal Degradation
Early work suggested that proteasomal targeting requires
a lysine 48 (K48)-linked ubiquitin chain consisting of at least
four conjoined ubiquitin molecules. This was based first upon
the biochemical analysis of chains formed on a model substrate,
b-galactosidase, in a reticulocyte lysate system and second
upon studies showing that unique among lysine mutant versions
of ubiquitin, K48R cannot serve as the sole source of ubiquitin in
yeast (Finley, 2009; Xu et al., 2009). The affinity of unanchored
K48 polyubiquitin chains for the proteasome increases more
than 100-fold from di- to tetraubiquitin (170 nM) and less
steeply thereafter (Thrower et al., 2000).
A body of work now suggests that in fact the proteasome
happily accepts other ubiquitin chain types. Indirect evidence
for this comes from the observation that acute proteasome inhi-
bition does not lead to the selective accumulation of K48 chains.
Rather, all chain types with the exception of K63 are increased
(Jacobson et al., 2009; Xu et al., 2009). During cell division, the
human anaphase-promoting complex (APC/C) recruits two E2
ligases (UbcH10 and Ube2S), which combine to exclusively
generate K11-linked chains on substrates. Loss of this unit leads
to strong defects in mitotic progression due to failure of the
necessary degradation processes (Song and Rape, 2010).
In vitro studies have even shown that K63-modified dihydrofo-
late reductase provides an efficient proteasome substrate
(Hofmann and Pickart, 1999).
The proteasome is composed of a core (20S) particle contain-
ing multiple proteolytic sites and a 19S regulatory particle that
Figure 1. Ubiquitin Is a Common Denominator of Protein Degrada-
tion Pathways
Specific ubiquitin receptors are associated with each degradation pathway.
Autophagosomal and multivesicular body (MVB) pathways merge at the lyso-
some and share a dependence on v-ATPase activity (inhibited by bafilomycin).
Both pathways also share sensitivity to inhibitors of phosphoinositide 3-kinase
activity, such as wortmannin or 3-methyladenine, as the family member
hVPS34 is required both for recruitment of ESCRT (endosomal sorting
complex required for transport) components to MVBs and for expansion of
the double-membrane preautophagosomal structure. Proteasomal inhibitors
include lactacystin and epoxomicin.
Figure 2. Ubiquitin Recognition by the Major Degradative Pathways
Depiction of the ‘‘ubiquitin receptors’’ associated with each degradative
pathway. The domain structures shown are for the human representatives of
each protein family, except for yeast Ddi1, the human ortholog of which
does not contain a UBA domain. CB: clathrin-binding motif; CC: coiled coil;
ESCRT: endosomal sorting complex required for transport; GGA: golgi-asso-
ciated, gamma adaptin ear containing, ARF-binding protein; GAE: gamma
adaptin ear; GAT: GGA and TOM1; GLUE: GRAM-like ubiquitin-binding in
Eap45; HRS: HGF receptor tyrosine kinase substrate; LIR: LC3-interacting
region; PB1: Phox and Bem1; PRU: Pleckstrin-like receptor for ubiquitin;
SH3: Src homology domain 3; STAM: signal transducing adaptor molecule;
TOM1: target of myb1; TSG101: tumor susceptibility gene 101; UBA: ubiqui-
tin-associated domain; UBL: ubiquitin-like domain; UEV: ubiquitin E2 variant
domain; UIM: ubiquitin-interacting motif; VHS: Vps27, HRS, and STAM;
VPS36: vacuolar protein sorting 36; vWFA: von Willebrand Factor type A;
ZZ: zinc finger. Note the following gene names and commonly used alternative
names also apply: p62; SQSTM1 (sequestosome), NDP52; CALCOCO2,
UBQLN1; PLIC1; DSK2. Domain annotation based on PFAM and UNIPROT.governs access to the core. To enter the core, substrates must
be amenable to unfolding by a hexamer of ATPases associated
with the base of the regulatory particle. Other constituents of the
regulatory particle are implicated in the recruitment of substrates
(Finley, 2009). Rpn10 and Rpn13 interact with ubiquitinated
substrates through UIM (ubiquitin-interacting motif) domains
and a Pru (pleckstrin-like receptor for ubiquitin) domain, respec-
tively. The UBL/UBA family of proteins are substoichiometric
components of purified proteasomes that bind ubiquitin via their
UBA (ubiquitin-associated) domain and the proteasome regula-
tory particle through its UBL (ubiquitin-like) domain. They are
proposed to remotely scavenge ubiquitinated substrates and
present them to the proteasome (Figure 2). Particular protea-
some-associated ubiquitin receptors have been linked with the
degradation of specific substrates (reviewed in Finley, 2009).
The mammalian regulatory particle has three associated deu-
biquitinating enzymes (DUBs), POH1/PSMD14, USP14, and
UCH37 (Rpn11 and Ubp6 in budding yeast), which have distinct
specificities for different chain linkages (Finley, 2009).What is the
function of these DUB activities? One important function is to
salvage ubiquitin in order to maintain the cellular ubiquitin pool.
The JAMM/MPN+ metalloprotease POH1 is thought to specifi-
cally disassemble K63-linked chains, as well as cleave the
isopeptide bond that links the substrate and the proximal ubiqui-
tin, allowing for en bloc removal of an ubiquitin chain. It also
governs entry into the central proteolytic chamber, thereby
coupling substrate degradation to recycling of ubiquitin (Yao
and Cohen, 2002). Ubiquitin-aldehyde-sensitive cysteineprotease activities (that is, USP14 and UCH37) account for all
activity directed toward K48-linked chains and also contribute
to K63-linked chain disassembly (Jacobson et al., 2009). One
attractive notion is that the integration of these DUB activities
may provide for a proof-reading mechanism, facilitating release
from the proteasome if commitment to degradation is not
accomplished within a given time window. For example, prefer-
ential proteasomal DUB activity against K63-linked chains has
been proposed to select against these substrates for degrada-
tion (Jacobson et al., 2009). Also in line with this principal,Cell 143, November 24, 2010 ª2010 Elsevier Inc. 683
a specific chemical inhibitor of USP14 has recently been shown
to enhance the rate of protein degradation (Lee et al., 2010).
In yeast, a ubiquitin ligase, Hul5 (mammalian ortholog is
KIAA10/E3a), that is associated with proteasomes can oppose
Ubp6 activity through chain elongation (E4) (Crosas et al.,
2006). Thus a balance between proteasome-associated ubiqui-
tin ligase and DUB activity may determine receptor fate.
Endolysosomal Degradation
The lysosomal degradation pathway is the principle means by
whichacell turnsoverplasmamembraneproteins, suchas recep-
tors or channels. Its defining characteristic is a requirement for
organelle acidification, mediated by the v-ATPase. Endocytosed
proteins are either recycled to the plasmamembrane or captured
into lumenal vesicles of the multivesicular body (MVB) as it
matures from the sorting endosome, before fusing directly with
lysosomes. Some receptors use ubiquitin as an internalization
signal, but for other ubiquitinated receptors, such as epidermal
growth factor receptor, this is secondary to, or redundant with,
other adaptor-binding motifs. Ubiquitination directs internalized
proteins toward lysosomal degradation by engagement with en-
dosomal sorting complexes required for transport (ESCRTs) (re-
viewed in Clague and Urbe´, 2006). Monoubiquitination, in the
formofan irreversible linear fusion appended to various receptors,
is a sufficient signal for this sorting step. However, evidence
suggestsK63as theprimary ubiquitin chain type involved in endo-
somal sorting. Early studies in yeast cells, which suggested that
appendage of K63-linked diubiquitin enhances vacuolar sorting,
have been recently elaborated on with a detailed analysis of the
downregulation of the Gap1 permease. These studies conclude
that monoubiquitination is sufficient for initial internalization (at
least so long as it is an irreversible linear fusion) but that efficient
sorting at the endosome by the ESCRT machinery requires K63-
linked polyubiquitin (Lauwers et al., 2009). Concordantly, studies
of the mammalian TrkA andMHC class I proteins reveal their utili-
zation of K63-linked polyubiquitination for routing to the lysosome
(Duncan et al., 2006; Geetha and Wooten, 2008).
The first point of engagement of ubiquitinated cargo with the
MVB sortingmachinery is proposed to be the ESCRT-0 complex,
comprisingHRS andSTAM, both of which possessUIM andVHS
(Vps27, HRS, and STAM) domains, which can bind ubiquitin
(Figure 2). Intact ESCRT-0 binds 50 times more tightly to K63-
linked tetraubiquitin than to monoubiquitin, but only 2-fold more
tightly than to K48-tetraubiquitin (Ren and Hurley, 2010).
ESCRT-0 is recruited to endosomes throughbinding to phospha-
tidylinositol 3-phosphate but also binds to clathrin and the down-
stream ESCRT-I complex. An alternative ESCRT-0 complex
comprising TOM1, Tollip, and Endofin possesses all these salient
features of the HRS-STAM complex. It is currently unclear
whether these two complexes are redundant or used to receive
different cargoes. In a further striking parallel to the proteasomal
system, the ESCRT machinery has known associations with at
least two DUB activities, AMSH and USP8 (UBPY), drawn from
the JAMM/MPN+ and USP families, respectively. In yeast, the
dominant endocytic E3 ligase activity Rsp5 can also associate
with the STAM ortholog Hse1, providing a counterbalance to
Ubp2 and Ubp7 (Ren et al., 2007), while a third ESCRT-associ-
ated DUB Doa4 is required for ubiquitin recycling of receptors684 Cell 143, November 24, 2010 ª2010 Elsevier Inc.that are committed to degradation. Although deubiquitination is
not an obligate step for MVB sorting, proof-reading and ubiquitin
recycling roles akin to those suggested for proteasomal DUBs
are consistent with available data (Clague and Urbe´, 2006).
Autophagy
The signature of autophagy is the capture of cytosol and organ-
elles through envelopment within a double-membrane compart-
ment derived from the preautophagosomal structure. In
common with the MVB, the autophagosome can then directly
fuse with late endosomes or lysosomes to form the autolyso-
some, wherein the double-membrane structure is digested. It
is well suited for the digestion of cytosolic entities, which are
incompatible with unfolding by the proteasome, such as organ-
elles or protein aggregates.
Identification of autophagy (Atg) genes and subsequent
biochemical characterization revealed two essential posttransla-
tional modification pathways, which resemble ubiquitination.
In one case, Atg12 is stably conjugated to Atg5 in a constitutive
fashion. In the second case, Atg8 is conjugated to the lipid phos-
phatidylethanolamineby transfer fromanE2enzyme following the
onset of autophagy (for example, as inducedbyaminoaciddepra-
vation). This is a prerequisite for the expansion of the preautopha-
gosomal structure, perhaps by facilitating fusion between
membranes. Inmammaliancells,Atg8 is knownasLC3and its lipi-
dated form as LC3-II. In fact, there are six Atg8 homologs in the
human genome collectively known as the LC3/GABARAP family.
Whereas autophagy is generally thought of as a nonselective
degradation process, certain structures and organelles are selec-
tively removed by this pathway. For example, mitochondria are
lost during reticulocyte maturation and as a consequence of un-
coupling (disconnecting the electron transport chain from ATP
production) in cultured cells. Ribosomes, peroxisomes, and path-
ophysiological protein aggregates can also be degraded by
autophagy. Recent studies have led to the proposal of a common
principle involved in ‘‘selective autophagies’’ andonceagainubiq-
uitin plays a critical role (Kirkin et al., 2009). In general if the body to
be cleared is ubiquitinated, then an adaptor molecule is required
to couple this to the preautophagosomal membrane rich in
Atg8/LC3. The prototypical adaptor of this class is p62/sequesto-
some 1,which contains both a ubiquitin-interacting domain (UBA)
and a LIR motif (LC3-interacting region), a domain structure
shared with Neighbor of BRCA1 gene 1 (NBR1) (Figure 2) (Pankiv
et al., 2007). p62 has been previously implicated in the clearing of
protein aggregates, which are known to be concentrated in ubiq-
uitin. Recent data have indicated an essential role for ubiquitin
(K63 and K27 polyubiquitin chain linkages have been implicated)
in the selective autophagy of depolarized mitochondria, which
become ubiquitinated following recruitment of the E3 ubiquitin
ligase Parkin (Geisler et al., 2010). Using a lysine-less mutant of
ubiquitin fusedwith red fluorescent protein, Kim et al. established
that irreversible monoubiquitination is sufficient to concentrate
a soluble protein within autophagosomal structures in a p62-
dependent manner (Kim et al., 2008).
A selective pathway requiring the Ubp3:Bre5 DUB complex in
Saccharomycescerevisiaeoperates in the removal ofmature ribo-
somes (Kraft andPeter, 2008). Incellsdeficient inUbp3, ribosomal
fractions are enriched with ubiquitin. Although an intimate
connection has been established, the exact role of ubiquitin in ri-
bophagy is unclear. One model posits that ubiquitin may be pro-
tecting ribosomes from autophagy, which is then promoted by
Ubp3 activity. Alternatively, a dynamicmodification with ubiquitin
maybe required, perhapsasanengulfment signal similar to that of
mitochondria. In support of this notion, a temperature-sensitive
defect in the E3 ligase Rsp5 shows a synthetic ribophagy defect
with lossofUbp3ascomparedwithcells lackingUbp3alone (Kraft
andPeter, 2008). If correct, then the principle of ensuring ubiquitin
homeostasis through deubiquitinationmay be conserved by each
of the selective degradation pathways we have discussed.
The Interdependence of Degradation Pathways
The relative contribution of degradation pathways may vary
greatly between cell types. In most cases of cells cultured under
stress-free conditions, proteasomal degradation predominates,
but in muscle cells, lysosomal pathways (principally autophagy)
can account for 40% of degradation of long-lived proteins. In
atrophying muscle cells, both pathways are proposed to be
co-ordinately upregulated under the transcriptional control of
FOXO3 (Zhao et al., 2007). However, the proteasome is itself
degraded by starvation-induced bulk autophagy (Kristensen
et al., 2008).
The reliance of three major cellular degradation pathways
upon ubiquitination suggests that specific inhibition of any one
pathway may perturb the ubiquitin economy of the cell and
hence indirectly affect other degradation events (Figure 1).
A clear example of this is the activated Met receptor, for which
its lysosomal degradation is exquisitely sensitive to the depletion
in free ubiquitin caused by proteasomal inhibition (Carter et al.,
2004). Proteasome inhibition may also induce autophagy as
a compensatory response. The autophagy adaptor protein p62
has also been implicated in proteasomal degradation, whereas
the E3 ligase Parkin generates an autophagy tag on mitochon-
dria but elsewhere can target proteins to the proteasome.
VCP/p97 co-ordinates a number of ubiquitin-dependent
processes that include the proteasome-dependent ERAD (endo-
plasmic reticulum-associated degradation) pathway but inter-
estingly has recently been identified as a necessary factor for
autophagosome maturation under basal conditions and
following proteasome inhibition (Tresse et al., 2010).
The MVB and autophagy pathways merge at the late endo-
some/lysosome and are both sensitive to proton pump and
phosphoinositide 3-kinase inhibitors. Autophagosome formation
is inherently sensitive to perturbations earlier in the endocytic
pathway, which change the character of later endosomal
compartments (such as the composition of SNARE proteins).
Occasionally, teleological distinctions between these systems
blur, such that some ubiquitinated cytosolic proteins may be
degraded in the lysosome and cytoplasm-exposed domains of
receptors may be nibbled by the proteasome. Mounting
evidence suggests that there is a proteasome pool associated
with endosomes that influences receptor sorting (Geetha and
Wooten, 2008; Gorbea et al., 2010).
Concluding Remarks
Ubiquitin tagging is common to the threemajor cellular pathways
for protein degradation. Herein lies a conundrum: how is a givensubstrate targeted to a particular pathway? Variable parameters
include location, chain length, and linkage type. A clear bias of
the endosomal pathway toward K63-linked chains has emerged.
This may simply reflect the subcellular localization of specific
E3 ligases in combination with a high local concentration of ubiq-
uitin-binding proteins, which couple to the ESCRT-machinery
rather than the proteasome. New techniques allow for the deter-
mination of individual protein turnover on a global scale (Kristen-
sen et al., 2008). This will enable the generation of a comprehen-
sive annotation of turnover rates as a function of experimental
perturbations or disease states, opening the door to
a systems-level understanding of protein degradation.
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